Strategies · US Venture

Backing US biotech from pre-seed to Series A.

Investing in US teams and companies whose edge is scientific.

We invest in early-stage companies with a differentiated scientific capability and a team committed to developing it. Our focus includes academic spinouts and companies built around proprietary technology, biological insight or data.

Stage
Pre-seed, seed and Series A
Geography
United States
Focus
Medicine, biotechnology and bioengineering
What we look for

Five things we look for in early-stage investments.

01

A capability that matters

A clear answer to “why now”: causal target biology, design-to-spec or a delivery unlock, with high potential for impact.

02

Research at the frontier

Teams whose work is published in leading peer-reviewed journals and who are recognized in their fields.

03

Protected IP

Differentiated intellectual property developed by, or with, the scientific founders.

04

A testable path to evidence

A credible go/no-go the next round can fund, not just a hypothesis.

05

A team that can build

Founders who can turn the science into commercializable products and solutions.

US Venture

Building a biotech company?

Get in touch with our venture team.